Hwang Se Hwan, Park In Joon, Cho Young Jin, Jeong Yeon Min, Kang Jun Myung
Department of Otolaryngology-Head and Neck Surgery, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Laryngoscope. 2016 Feb;126(2):357-66. doi: 10.1002/lary.25636. Epub 2015 Sep 25.
OBJECTIVES/HYPOTHESIS: Gabapentin and pregabalin are useful for treating neuropathic pain because of their antiallodynic and antihyperalgesic properties, which may be beneficial in managing acute postoperative pain. The goal of this meta-analysis was to perform a systematic review of the literature on the effect of gabapentinoids on postoperative pain following tonsillectomy, and its adverse effects in patients. DATA SOURCES: MEDLINE, SCOPUS, and Cochrane database. METHODS: Two authors independently searched the databases from their inception of article collection to May 2015. Included in the analysis were studies that compared preoperative gabapentinoid administration (gabapentinoids groups) with a placebo or pain control agent (control group) during a 24-hour postoperative period, the outcomes of interest being postoperative pain intensity; rescue analgesic consumption; or adverse effects such as sedation, nausea and vomiting, dizziness, and headache. RESULTS: The pain score reported by the physician during the first 8 hours, as well as the need for analgesics during 24 hours postoperatively, were significantly decreased in the gabapentinoids group versus the control group. Additionally, there was no significant difference between gabapentinoids and control groups for adverse effect during 24 hours postoperatively. In the subgroup analyses (gabapentin and pregabalin) regarding pain-related measurements, two subgroups showed the similar effect on reducing the postoperative pain severity. CONCLUSION: Preoperative administration of gabapentinoids could provide pain relief without side effects in patients undergoing tonsillectomy. However, considering the insufficient evaluation of efficacy of gabapentinoids according to the high heterogeneity in some parameters, further clinical trials with robust research methodology should be conducted in order to confirm the results of this study. LEVEL OF EVIDENCE: NA.
目的/假设:加巴喷丁和普瑞巴林因其抗痛觉过敏和抗痛觉超敏特性而可用于治疗神经性疼痛,这可能有助于处理急性术后疼痛。本荟萃分析的目的是对有关加巴喷丁类药物对扁桃体切除术后疼痛的影响及其对患者不良反应的文献进行系统综述。 数据来源:MEDLINE、SCOPUS和Cochrane数据库。 方法:两位作者独立检索数据库,检索时间从文章收录起始至2015年5月。纳入分析的研究为在术后24小时内将术前给予加巴喷丁类药物(加巴喷丁类药物组)与安慰剂或疼痛控制药物(对照组)进行比较的研究,感兴趣的结局指标为术后疼痛强度、补救性镇痛药消耗量,或诸如镇静、恶心和呕吐、头晕及头痛等不良反应。 结果:与对照组相比,加巴喷丁类药物组在术后最初8小时内医生报告的疼痛评分以及术后24小时内的镇痛药需求均显著降低。此外,加巴喷丁类药物组与对照组在术后24小时内的不良反应方面无显著差异。在关于疼痛相关测量的亚组分析(加巴喷丁和普瑞巴林)中,两个亚组在减轻术后疼痛严重程度方面显示出相似的效果。 结论:术前给予加巴喷丁类药物可为接受扁桃体切除术的患者缓解疼痛且无副作用。然而,考虑到一些参数存在高度异质性,加巴喷丁类药物的疗效评估不足,因此应采用可靠的研究方法进行进一步的临床试验,以证实本研究结果。 证据水平:无。
Cochrane Database Syst Rev. 2017-8-5
BMC Musculoskelet Disord. 2016-8-30
Cochrane Database Syst Rev. 2017-8-5
Cochrane Database Syst Rev. 2012-7-11
Eur Arch Otorhinolaryngol. 2024-3
World J Otorhinolaryngol Head Neck Surg. 2021-5-29
Iran J Otorhinolaryngol. 2020-7
Br J Anaesth. 2019-6-17